It’s back - IR magazine’s DR update. Given that the year is almost up, this blog will take a look back over some market changes from 2009, and speculate how they will play out in 2010, with comment from JP Morgan’s global head of DRs Claudine Gallagher.
Brazil’s ADR tax
Emerging markets have taken the lion’s share of equity investment over the past year, causing some developing countries to worry about inflation and currency appreciation.
To combat this, Brazil brought in a 2 percent tax on foreign currency inflows in October of this year, followed by a 1.5 percent tax on the ADR programs of all Brazilian companies the next month. Banco Santander’s Brazil unit narrowly avoided the tax when raising $8 bn through an IPO in early October, $4.5 bn of which was in DR form.
At the time the moves shocked market participants, but the DR market appears to have come through unscathed. ‘What we’re seeing is issuance and cancellations at the same levels as before the 1.5 percent ADR tax and the 2 percent foreign exchange tax, so we’re practically back to normal,’ says Gallagher.
‘There’s still volume out there and a lot of interest in Brazil. From what I’m hearing, we’ll see some big programs coming out of Brazil over the course of the next year,’ she adds.
Russia’s regulatory shuffle
Russia has also seen regulatory changes affecting the DR market. In its case, the authorities want to protect local liquidity. Russia already has rules restricting the amount of shares a domestic company can offer abroad to 30 percent. This limit is being lowered from January 2010 to 25 percent for companies on quotation list ‘A’ of the Russia stock exchange, and 15 percent for those on quotation list ‘B’, according to JP Morgan.
But other changes will help boost the market for DRs by Russian companies. The changes also allow Russian issuers to list DRs without raising new capital – previously this was not permitted – allowing them to set up level 1 programs in the US on the over-the-counter market.
‘There is a lot of investor interest for some of those large companies in Russia that maybe don’t need to raise capital now but may want to in the future,’ says Gallagher. ‘Russia has been largely absent from the DR market this year but I think it will be back in 2010.’
Continuation of US delistings
Gallagher sees a continuation of the delistings from the main stock market that began a couple of years ago when the SEC made it easier for overseas companies to deregister.
She points out, though, that most continue to be traded on the over-the-counter market OTCQX. ‘Companies are making the move for two reasons,’ she explains. ‘One, they have very small trading volumes and it didn’t pay to remain on the main exchange; or two, they have good brand awareness and investor interest and can continue to see strong trading and liquidity even though they’re on the OTCQX market.’
End-of-year review
JP Morgan has produced a report reviewing the DR market during 2009. Some of the main findings are listed below:
-DR trading was slightly lower in 2009 than 2008, with 124 bn DR shares traded in the 11 months to November this year, compared to 131 bn during the same period last year.
-There were 91 new ADR and GDR programs in the first 11 months of 2009, taking the total number of sponsored programs to 2,122.
-Capital raising through ADRs and GDRs to November increased by 68 percent on last year, raising around $8 bn, with the majority of that through ADRs listed in New York.
-The top five IPO issuers up to November in 2009 were:
Banco Santander – $4.507 bn
Shanda Games – $1.043 bn
Shin Kong Financial Holdings – $375 mn
Epistar – $351 mn
KGI Securities Co – $286 mn
Tim Human
IR magazine